Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, is joined by Jackie Gerhart, M.D., chief medical officer of Epic and a ...
In this Leadership Dialogue, I’m joined by Jackie Gerhart, M.D., chief medical officer of Epic and a practicing family medicine physician.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback